{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:36:31Z","timestamp":1787319391215,"version":"build-2736575974"},"reference-count":91,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T00:00:00Z","timestamp":1735862400000},"content-version":"vor","delay-in-days":368,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Global Medical Genetics"],"published-print":{"date-parts":[[2024]]},"DOI":"10.1055\/s-0044-1790558","type":"journal-article","created":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T09:16:21Z","timestamp":1727255781000},"page":"319-329","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Mechanism of Genome Editing Tools and Their Application on Genetic Inheritance Disorders"],"prefix":"10.1016","volume":"11","author":[{"given":"Dae Hwan","family":"Oh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7603","key":"10.1055\/s-0044-1790558_bib1","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/nature17946","article-title":"Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage","volume":"533","author":"Komor","year":"2016","journal-title":"Nature"},{"issue":"7785","key":"10.1055\/s-0044-1790558_bib2","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41586-019-1711-4","article-title":"Search-and-replace genome editing without double-strand breaks or donor DNA","volume":"576","author":"Anzalone","year":"2019","journal-title":"Nature"},{"issue":"05","key":"10.1055\/s-0044-1790558_bib3","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.cct.2010.06.007","article-title":"Creating a global rare disease patient registry linked to a rare diseases biorepository database: rare disease-HUB (RD-HUB)","volume":"31","author":"Rubinstein","year":"2010","journal-title":"Contemp Clin Trials"},{"issue":"03","key":"10.1055\/s-0044-1790558_bib4","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.ymthe.2019.12.010","article-title":"AAV vector immunogenicity in humans: a long journey to successful gene transfer","volume":"28","author":"Verdera","year":"2020","journal-title":"Mol Ther"},{"issue":"03","key":"10.1055\/s-0044-1790558_bib5","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1086\/595830","article-title":"Worldwide epidemiology of neutralizing antibodies to adeno-associated viruses","volume":"199","author":"Calcedo","year":"2009","journal-title":"J Infect Dis"},{"issue":"09","key":"10.1055\/s-0044-1790558_bib6","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1080\/14712598.2022.2060737","article-title":"Addressing high dose AAV toxicity - \u2019one and done\u2019 or \u2019slower and lower\u2019?","volume":"22","author":"Kishimoto","year":"2022","journal-title":"Expert Opin Biol Ther"},{"issue":"01","key":"10.1055\/s-0044-1790558_bib7","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1046\/j.1365-2958.2000.01838.x","article-title":"Biological significance of a family of regularly spaced repeats in the genomes of archaea, bacteria and mitochondria","volume":"36","author":"Mojica","year":"2000","journal-title":"Mol Microbiol"},{"key":"10.1055\/s-0044-1790558_bib8","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms13350","article-title":"Structural roles of guide RNAs in the nuclease activity of Cas9 endonuclease","volume":"7","author":"Lim","year":"2016","journal-title":"Nat Commun"},{"issue":"04","key":"10.1055\/s-0044-1790558_bib9","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1080\/15476286.2018.1504546","article-title":"PAM identification by CRISPR-Cas effector complexes: diversified mechanisms and structures","volume":"16","author":"Gleditzsch","year":"2019","journal-title":"RNA Biol"},{"issue":"07","key":"10.1055\/s-0044-1790558_bib10","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/s41587-020-0561-9","article-title":"Genome editing with CRISPR-Cas nucleases, base editors, transposases and prime editors","volume":"38","author":"Anzalone","year":"2020","journal-title":"Nat Biotechnol"},{"issue":"24","key":"10.1055\/s-0044-1790558_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21249604","article-title":"Various aspects of a gene editing system\u2014CRISPR\u2013Cas9","volume":"21","author":"Janik","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"11","key":"10.1055\/s-0044-1790558_bib12","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1042\/BCJ20170793","article-title":"CRISPR base editors: genome editing without double-stranded breaks","volume":"475","author":"Eid","year":"2018","journal-title":"Biochem J"},{"issue":"10","key":"10.1055\/s-0044-1790558_bib13","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.tibtech.2019.03.008","article-title":"CRISPR\/Cas-mediated base editing: technical considerations and practical applications","volume":"37","author":"Molla","year":"2019","journal-title":"Trends Biotechnol"},{"issue":"04","key":"10.1055\/s-0044-1790558_bib14","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nmeth.2857","article-title":"Efficient genome modification by CRISPR-Cas9 nickase with minimal off-target effects","volume":"11","author":"Shen","year":"2014","journal-title":"Nat Methods"},{"key":"10.1055\/s-0044-1790558_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.ggedit.2021.100005","article-title":"Base editor: expanding the types of DNA damage products harnessed for genome editing","author":"Gu","year":"2021","journal-title":"Gend Genome Ed"},{"issue":"05","key":"10.1055\/s-0044-1790558_bib16","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1042\/ETLS20190088","article-title":"Base editors: modular tools for the introduction of point mutations in living cells","volume":"3","author":"Evanoff","year":"2019","journal-title":"Emerg Top Life Sci"},{"issue":"12","key":"10.1055\/s-0044-1790558_bib17","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/s41576-018-0059-1","article-title":"Base editing: precision chemistry on the genome and transcriptome of living cells","volume":"19","author":"Rees","year":"2018","journal-title":"Nat Rev Genet"},{"key":"10.1055\/s-0044-1790558_bib18","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1146\/annurev.biochem.73.012803.092453","article-title":"Flap endonuclease 1: a central component of DNA metabolism","volume":"73","author":"Liu","year":"2004","journal-title":"Annu Rev Biochem"},{"issue":"03","key":"10.1055\/s-0044-1790558_bib19","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20150058","article-title":"Human exonuclease 1 (EXO1) activity characterization and its function on flap structures","volume":"35","author":"Keijzers","year":"2015","journal-title":"Biosci Rep"},{"issue":"08","key":"10.1055\/s-0044-1790558_bib20","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aao4774","article-title":"Improved base excision repair inhibition and bacteriophage Mu Gam protein yields C:G-to-T:A base editors with higher efficiency and product purity","volume":"3","author":"Komor","year":"2017","journal-title":"Sci Adv"},{"issue":"D1","key":"10.1055\/s-0044-1790558_bib21","doi-asserted-by":"crossref","first-page":"D862","DOI":"10.1093\/nar\/gkv1222","article-title":"ClinVar: public archive of interpretations of clinically relevant variants","volume":"44","author":"Landrum","year":"2016","journal-title":"Nucleic Acids Res"},{"issue":"06","key":"10.1055\/s-0044-1790558_bib22","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1111\/hae.14179","article-title":"The challenge of genetically unresolved haemophilia A patients: interest of the combination of whole F8 gene sequencing and functional assays","volume":"26","author":"Lassalle","year":"2020","journal-title":"Haemophilia"},{"issue":"07","key":"10.1055\/s-0044-1790558_bib23","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1055\/s-0032-1326786","article-title":"The diagnosis and management of congenital hemophilia","volume":"38","author":"Carcao","year":"2012","journal-title":"Semin Thromb Hemost"},{"issue":"08","key":"10.1055\/s-0044-1790558_bib24","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1111\/j.1538-7836.2005.01375.x","article-title":"Cellular immune responses in hemophilia: why do inhibitors develop in some, but not all hemophiliacs?","volume":"3","author":"White","year":"2005","journal-title":"J Thromb Haemost"},{"issue":"01","key":"10.1055\/s-0044-1790558_bib25","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s12185-018-2545-9","article-title":"Emicizumab, a humanized bispecific antibody to coagulation factors IXa and X with a factor VIIIa-cofactor activity","volume":"111","author":"Kitazawa","year":"2020","journal-title":"Int J Hematol"},{"issue":"07","key":"10.1055\/s-0044-1790558_bib26","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1097\/MBC.0b013e32833c2bb5","article-title":"The use of desmopressin in mild hemophilia A","volume":"21","author":"Franchini","year":"2010","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"08","key":"10.1055\/s-0044-1790558_bib27","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1055\/s-0042-1756188","article-title":"The more recent history of hemophilia treatment","volume":"48","author":"Franchini","year":"2022","journal-title":"Semin Thromb Hemost"},{"issue":"01","key":"10.1055\/s-0044-1790558_bib28","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s12185-018-2513-4","article-title":"Advances in gene therapy for hemophilia: basis, current status, and future perspectives","volume":"111","author":"Ohmori","year":"2020","journal-title":"Int J Hematol"},{"issue":"25","key":"10.1055\/s-0044-1790558_bib29","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1056\/NEJMoa1108046","article-title":"Adenovirus-associated virus vector-mediated gene transfer in hemophilia B","volume":"365","author":"Nathwani","year":"2011","journal-title":"N Engl J Med"},{"issue":"03","key":"10.1055\/s-0044-1790558_bib30","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nm1358","article-title":"Successful transduction of liver in hemophilia by AAV-factor IX and limitations imposed by the host immune response","volume":"12","author":"Manno","year":"2006","journal-title":"Nat Med"},{"issue":"10","key":"10.1055\/s-0044-1790558_bib31","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1182\/blood-2006-04-017913","article-title":"Effects of transient immunosuppression on adenoassociated, virus-mediated, liver-directed gene transfer in rhesus macaques and implications for human gene therapy","volume":"108","author":"Jiang","year":"2006","journal-title":"Blood"},{"issue":"01","key":"10.1055\/s-0044-1790558_bib32","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-04625-5","article-title":"CRISPR\/Cas9-mediated genome editing via postnatal administration of AAV vector cures haemophilia B mice","volume":"7","author":"Ohmori","year":"2017","journal-title":"Sci Rep"},{"key":"10.1055\/s-0044-1790558_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.672564","article-title":"CRISPR\/Cas9-mediated in vivo genetic correction in a mouse model of hemophilia A","volume":"9","author":"Luo","year":"2021","journal-title":"Front Cell Dev Biol"},{"issue":"02","key":"10.1055\/s-0044-1790558_bib34","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s12185-019-02765-0","article-title":"CRISPR\/Cas9-mediated gene correction in hemophilia B patient-derived iPSCs","volume":"111","author":"Morishige","year":"2020","journal-title":"Int J Hematol"},{"issue":"01","key":"10.1055\/s-0044-1790558_bib35","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1182\/blood-2020-142679","article-title":"Specific correction of the intron-22 inverted factor VIII gene in autologous blood outgrowth endothelial cells from patients with severe hemophilia A","volume":"136","author":"Dinh","year":"2020","journal-title":"Blood"},{"issue":"01","key":"10.1055\/s-0044-1790558_bib36","article-title":"Efficient targeted integration into the bovine Rosa26 locus using TALENs","volume":"8","author":"Wang","year":"2018","journal-title":"Sci Rep"},{"issue":"03","key":"10.1055\/s-0044-1790558_bib37","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1089\/hum.2009.100","article-title":"Optimized adenoassociated virus (AAV)-protein phosphatase-5 helper viruses for efficient liver transduction by single-stranded AAV vectors: therapeutic expression of factor IX at reduced vector doses","volume":"21","author":"Jayandharan","year":"2010","journal-title":"Hum Gene Ther"},{"key":"10.1055\/s-0044-1790558_bib38","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.thromres.2024.04.031","article-title":"AAV mediated genome engineering with a bypass coagulation factor alleviates the bleeding phenotype in a murine model of hemophilia B","volume":"238","author":"Sarangi","year":"2024","journal-title":"Thromb Res"},{"issue":"01","key":"10.1055\/s-0044-1790558_bib39","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/s41392-021-00642-z","article-title":"Membrane-destabilizing ionizable phospholipids: novel components for organ-selective mRNA delivery and CRISPR-Cas gene editing","volume":"6","author":"Meng","year":"2021","journal-title":"Signal Transduct Target Ther"},{"issue":"03","key":"10.1055\/s-0044-1790558_bib40","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abj6901","article-title":"In vivo delivery of CRISPR-Cas9 using lipid nanoparticles enables antithrombin gene editing for sustainable hemophilia A and B therapy","volume":"8","author":"Han","year":"2022","journal-title":"Sci Adv"},{"issue":"6408","key":"10.1055\/s-0044-1790558_bib41","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1126\/science.aas9129","article-title":"Engineered CRISPR-Cas9 nuclease with expanded targeting space","volume":"361","author":"Nishimasu","year":"2018","journal-title":"Science"},{"issue":"6305","key":"10.1055\/s-0044-1790558_bib42","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaf8729","article-title":"Targeted nucleotide editing using hybrid prokaryotic and vertebrate adaptive immune systems","volume":"353","author":"Nishida","year":"2016","journal-title":"Science"},{"issue":"13","key":"10.1055\/s-0044-1790558_bib43","doi-asserted-by":"crossref","first-page":"6450","DOI":"10.1093\/nar\/gkv601","article-title":"Development of an intein-mediated split-Cas9 system for gene therapy","volume":"43","author":"Truong","year":"2015","journal-title":"Nucleic Acids Res"},{"issue":"01","key":"10.1055\/s-0044-1790558_bib44","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s43856-023-00286-w","article-title":"PAM-flexible Cas9-mediated base editing of a hemophilia B mutation in induced pluripotent stem cells","volume":"3","author":"Hiramoto","year":"2023","journal-title":"Commun Med (Lond)"},{"issue":"06","key":"10.1055\/s-0044-1790558_bib45","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1172\/JCI109073","article-title":"Activation of human factor IX (Christmas factor)","volume":"61","author":"Di Scipio","year":"1978","journal-title":"J Clin Invest"},{"issue":"05","key":"10.1055\/s-0044-1790558_bib46","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1021\/acs.molpharmaceut.8b00044","article-title":"Bioinspired star-shaped poly(l-lysine) polypeptides: efficient polymeric nanocarriers for the delivery of DNA to mesenchymal stem cells","volume":"15","author":"Walsh","year":"2018","journal-title":"Mol Pharm"},{"key":"10.1055\/s-0044-1790558_bib47","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.bbrc.2022.08.076","article-title":"Delivery of Cas9-guided ABE8e into stem cells using poly(l-lysine) polypeptides for correction of the hemophilia-associated FIX missense mutation","volume":"628","author":"Rong","year":"2022","journal-title":"Biochem Biophys Res Commun"},{"issue":"09","key":"10.1055\/s-0044-1790558_bib48","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1517\/14656566.6.9.1517","article-title":"Haemophilia B: Christmas disease","volume":"6","author":"Giangrande","year":"2005","journal-title":"Expert Opin Pharmacother"},{"issue":"01","key":"10.1055\/s-0044-1790558_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2023.101177","article-title":"Genetic surgery for a cystic fibrosis-causing splicing mutation","volume":"32","author":"Bulcaen","year":"2024","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"07","key":"10.1055\/s-0044-1790558_bib50","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.tips.2007.05.004","article-title":"Molecular targeting of CFTR as a therapeutic approach to cystic fibrosis","volume":"28","author":"Amaral","year":"2007","journal-title":"Trends Pharmacol Sci"},{"key":"10.1055\/s-0044-1790558_bib51","article-title":"CFTR modulators: The changing face of cystic fibrosis in the era of precision medicine","volume":"10","author":"Miqu\u00e9ias","year":"2020","journal-title":"Front Pharmacol"},{"issue":"06","key":"10.1055\/s-0044-1790558_bib52","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.ymthe.2003.08.015","article-title":"Successful transgene expression with serial doses of aerosolized rAAV2 vectors in rhesus macaques","volume":"8","author":"Fischer","year":"2003","journal-title":"Mol Ther"},{"issue":"04","key":"10.1055\/s-0044-1790558_bib53","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/sj.mt.6300059","article-title":"Expression of a truncated cystic fibrosis transmembrane conductance regulator with an AAV5-pseudotyped vector in primates","volume":"15","author":"Fischer","year":"2007","journal-title":"Mol Ther"},{"issue":"08","key":"10.1055\/s-0044-1790558_bib54","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1089\/hum.2007.022","article-title":"Repeated aerosolized AAV-CFTR for treatment of cystic fibrosis: a randomized placebo-controlled phase 2B trial","volume":"18","author":"Moss","year":"2007","journal-title":"Hum Gene Ther"},{"issue":"02","key":"10.1055\/s-0044-1790558_bib55","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1378\/chest.125.2.509","article-title":"Repeated adeno-associated virus serotype 2 aerosol-mediated cystic fibrosis transmembrane regulator gene transfer to the lungs of patients with cystic fibrosis: a multicenter, double-blind, placebo-controlled trial","volume":"125","author":"Moss","year":"2004","journal-title":"Chest"},{"issue":"07","key":"10.1055\/s-0044-1790558_bib56","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1000155","article-title":"CFTR delivery to 25% of surface epithelial cells restores normal rates of mucus transport to human cystic fibrosis airway epithelium","volume":"7","author":"Zhang","year":"2009","journal-title":"PLoS Biol"},{"key":"10.1055\/s-0044-1790558_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2023.101140","article-title":"Molecular and functional correction of a deep intronic splicing mutation in CFTR by CRISPR-Cas9 gene editing","volume":"31","author":"Walker","year":"2023","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"06","key":"10.1055\/s-0044-1790558_bib58","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1172\/JCI115510","article-title":"Severe deficiency of cystic fibrosis transmembrane conductance regulator messenger RNA carrying nonsense mutations R553X and W1316X in respiratory epithelial cells of patients with cystic fibrosis","volume":"88","author":"Hamosh","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1055\/s-0044-1790558_bib59","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3389\/fgene.2018.00021","article-title":"Commentary: Programmable base editing of A\u00b7T to G\u00b7C in genomic DNA without DNA cleavage","volume":"9","author":"Matsoukas","year":"2018","journal-title":"Front Genet"},{"issue":"05","key":"10.1055\/s-0044-1790558_bib60","doi-asserted-by":"crossref","first-page":"L844","DOI":"10.1152\/ajplung.00355.2002","article-title":"Development of cystic fibrosis and noncystic fibrosis airway cell lines","volume":"284","author":"Zabner","year":"2003","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"04","key":"10.1055\/s-0044-1790558_bib61","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/s41587-020-0412-8","article-title":"Continuous evolution of SpCas9 variants compatible with non-G PAMs","volume":"38","author":"Miller","year":"2020","journal-title":"Nat Biotechnol"},{"issue":"18","key":"10.1055\/s-0044-1790558_bib62","doi-asserted-by":"crossref","first-page":"10558","DOI":"10.1093\/nar\/gkab788","article-title":"Functional correction of CFTR mutations in human airway epithelial cells using adenine base editors","volume":"49","author":"Krishnamurthy","year":"2021","journal-title":"Nucleic Acids Res"},{"issue":"06","key":"10.1055\/s-0044-1790558_bib63","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1101\/gr.171322.113","article-title":"Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins","volume":"24","author":"Kim","year":"2014","journal-title":"Genome Res"},{"issue":"01","key":"10.1055\/s-0044-1790558_bib64","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-04580-3","article-title":"In vivo base editing of post-mitotic sensory cells","volume":"9","author":"Yeh","year":"2018","journal-title":"Nat Commun"},{"issue":"05","key":"10.1055\/s-0044-1790558_bib65","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.ymthe.2003.08.014","article-title":"Improved system for helper-dependent adenoviral vector production","volume":"8","author":"Palmer","year":"2003","journal-title":"Mol Ther"},{"issue":"06","key":"10.1055\/s-0044-1790558_bib66","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1089\/hum.2017.201","article-title":"Transducing airway basal cells with a helper-dependent adenoviral vector for lung gene therapy","volume":"29","author":"Cao","year":"2018","journal-title":"Hum Gene Ther"},{"issue":"11","key":"10.1055\/s-0044-1790558_bib67","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0295009","article-title":"Prime editing-mediated correction of the CFTRW1282X mutation in iPSCs and derived airway epithelial cells","volume":"18","author":"Li","year":"2023","journal-title":"PLoS One"},{"issue":"01","key":"10.1055\/s-0044-1790558_bib68","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41572-021-00248-3","article-title":"Duchenne muscular dystrophy","volume":"7","author":"Duan","year":"2021","journal-title":"Nat Rev Dis Primers"},{"issue":"10","key":"10.1055\/s-0044-1790558_bib69","doi-asserted-by":"crossref","first-page":"800","DOI":"10.3390\/cells13100800","article-title":"CRISPR-based gene therapies: from preclinical to clinical treatments","volume":"13","author":"Laurent","year":"2024","journal-title":"Cells"},{"issue":"6254","key":"10.1055\/s-0044-1790558_bib70","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/343180a0","article-title":"Very mild muscular dystrophy associated with the deletion of 46% of dystrophin","volume":"343","author":"England","year":"1990","journal-title":"Nature"},{"issue":"08","key":"10.1055\/s-0044-1790558_bib71","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1212\/WNL.39.8.1011","article-title":"Improved diagnosis of Becker muscular dystrophy by dystrophin testing","volume":"39","author":"Hoffman","year":"1989","journal-title":"Neurology"},{"issue":"04","key":"10.1055\/s-0044-1790558_bib72","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.nmd.2010.01.013","article-title":"Becker muscular dystrophy patients with deletions around exon 51; a promising outlook for exon skipping therapy in Duchenne patients","volume":"20","author":"Helderman-van den Enden","year":"2010","journal-title":"Neuromuscul Disord"},{"key":"10.1055\/s-0044-1790558_bib73","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.ebiom.2019.06.036","article-title":"Peptide-conjugate antisense based splice-correction for Duchenne muscular dystrophy and other neuromuscular diseases","volume":"45","author":"Tsoumpra","year":"2019","journal-title":"EBioMedicine"},{"issue":"03","key":"10.1055\/s-0044-1790558_bib74","doi-asserted-by":"crossref","first-page":"232","DOI":"10.31662\/jmaj.2021-0019","article-title":"Antisense oligonucleotide-mediated exon-skipping therapies: precision medicine spreading from Duchenne muscular dystrophy","volume":"4","author":"Matsuo","year":"2021","journal-title":"JMA J"},{"issue":"10","key":"10.1055\/s-0044-1790558_bib75","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1016\/j.ymthe.2018.07.011","article-title":"Systemic AAV micro-dystrophin gene therapy for Duchenne muscular dystrophy","volume":"26","author":"Duan","year":"2018","journal-title":"Mol Ther"},{"issue":"6271","key":"10.1055\/s-0044-1790558_bib76","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1126\/science.aad5143","article-title":"In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy","volume":"351","author":"Nelson","year":"2016","journal-title":"Science"},{"issue":"03","key":"10.1055\/s-0044-1790558_bib77","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1089\/hum.2018.015","article-title":"Severe toxicity in nonhuman primates and piglets following high-dose intravenous administration of an adeno-associated virus vector expressing human SMN","volume":"29","author":"Hinderer","year":"2018","journal-title":"Hum Gene Ther"},{"issue":"08","key":"10.1055\/s-0044-1790558_bib78","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1038\/mt.2010.94","article-title":"Widespread muscle expression of an AAV9 human mini-dystrophin vector after intravenous injection in neonatal dystrophin-deficient dogs","volume":"18","author":"Kornegay","year":"2010","journal-title":"Mol Ther"},{"key":"10.1055\/s-0044-1790558_bib79","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.omtn.2022.07.024","article-title":"A humanized knockin mouse model of Duchenne muscular dystrophy and its correction by CRISPR-Cas9 therapeutic gene editing","volume":"29","author":"Zhang","year":"2022","journal-title":"Mol Ther Nucleic Acids"},{"issue":"09","key":"10.1055\/s-0044-1790558_bib80","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nbt.4172","article-title":"Improving cytidine and adenine base editors by expression optimization and ancestral reconstruction","volume":"36","author":"Koblan","year":"2018","journal-title":"Nat Biotechnol"},{"issue":"09","key":"10.1055\/s-0044-1790558_bib81","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/j.febslet.2009.03.058","article-title":"Solution structure of DnaE intein from Nostoc punctiforme: structural basis for the design of a new split intein suitable for site-specific chemical modification","volume":"583","author":"Oeemig","year":"2009","journal-title":"FEBS Lett"},{"issue":"18","key":"10.1055\/s-0044-1790558_bib82","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abg4910","article-title":"Precise correction of Duchenne muscular dystrophy exon deletion mutations by base and prime editing","volume":"7","author":"Chemello","year":"2021","journal-title":"Sci Adv"},{"issue":"13\u201314","key":"10.1055\/s-0044-1790558_bib83","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1089\/hum.2020.187","article-title":"AAV vectors: are they safe?","volume":"31","author":"Srivastava","year":"2020","journal-title":"Hum Gene Ther"},{"issue":"05","key":"10.1055\/s-0044-1790558_bib84","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.jcf.2021.06.003","article-title":"Antisense oligonucleotide-based drug development for cystic fibrosis patients carrying the 3849+10 kb C-to-T splicing mutation","volume":"20","author":"Oren","year":"2021","journal-title":"J Cyst Fibros"},{"key":"10.1055\/s-0044-1790558_bib85","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.pupt.2015.07.003","article-title":"Nanocomplexes for gene therapy of respiratory diseases: targeting and overcoming the mucus barrier","volume":"34","author":"Di Gioia","year":"2015","journal-title":"Pulm Pharmacol Ther"},{"issue":"08","key":"10.1055\/s-0044-1790558_bib86","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.tibtech.2023.03.004","article-title":"Prime editing: advances and therapeutic applications","volume":"41","author":"Zhao","year":"2023","journal-title":"Trends Biotechnol"},{"issue":"15","key":"10.1055\/s-0044-1790558_bib87","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aaz0051","article-title":"Improving the efficiency of precise genome editing with site-specific Cas9-oligonucleotide conjugates","volume":"6","author":"Ling","year":"2020","journal-title":"Sci Adv"},{"issue":"6448","key":"10.1055\/s-0044-1790558_bib88","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1126\/science.aax9181","article-title":"RNA-guided DNA insertionwith CRISPR-associated transposases","volume":"365","author":"Strecker","year":"2019","journal-title":"Science"},{"issue":"7764","key":"10.1055\/s-0044-1790558_bib89","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/s41586-019-1323-z","article-title":"Transposon-encoded CRISPR-Cas systems direct RNA-guided DNA integration","volume":"571","author":"Klompe","year":"2019","journal-title":"Nature"},{"issue":"05","key":"10.1055\/s-0044-1790558_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114225","article-title":"PAMless SpRYexhibits a preference for the seed region for efficient targeting","volume":"43","author":"Yang","year":"2024","journal-title":"Cell Rep"},{"key":"10.1055\/s-0044-1790558_bib91","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.isci.2019.05.008","article-title":"Developing ABEmax-NG with precise targeting and expanded editing scope to model pathogenic splice site mutations in vivo","volume":"15","author":"Huang","year":"2019","journal-title":"iScience"}],"container-title":["Global Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2699940425000323?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2699940425000323?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0044-1790558.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T07:37:02Z","timestamp":1761205022000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2699940425000323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":91,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024]]}},"alternative-id":["S2699940425000323"],"URL":"https:\/\/doi.org\/10.1055\/s-0044-1790558","relation":{},"ISSN":["2699-9404"],"issn-type":[{"value":"2699-9404","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanism of Genome Editing Tools and Their Application on Genetic Inheritance Disorders","name":"articletitle","label":"Article Title"},{"value":"Global Medical Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1055\/s-0044-1790558","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2024 International Knowledge Direct Medical Associations. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}